Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1996 2
1998 1
2001 1
2002 1
2003 3
2004 3
2005 1
2006 2
2008 1
2009 4
2010 5
2011 3
2012 2
2013 1
2014 4
2015 3
2016 1
2017 1
2018 1
2019 4
2020 5
2021 3
2022 3
2023 5
2024 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

56 results

Results by year

Filters applied: . Clear all
Page 1
Pembrolizumab for Persistent, Recurrent, or Metastatic Cervical Cancer.
Colombo N, Dubot C, Lorusso D, Caceres MV, Hasegawa K, Shapira-Frommer R, Tewari KS, Salman P, Hoyos Usta E, Yañez E, Gümüş M, Olivera Hurtado de Mendoza M, Samouëlian V, Castonguay V, Arkhipov A, Toker S, Li K, Keefe SM, Monk BJ; KEYNOTE-826 Investigators. Colombo N, et al. N Engl J Med. 2021 Nov 11;385(20):1856-1867. doi: 10.1056/NEJMoa2112435. Epub 2021 Sep 18. N Engl J Med. 2021. PMID: 34534429 Clinical Trial.
Carboplatin and paclitaxel plus avelumab compared with carboplatin and paclitaxel in advanced or recurrent endometrial cancer (MITO END-3): a multicentre, open-label, randomised, controlled, phase 2 trial.
Pignata S, Scambia G, Schettino C, Arenare L, Pisano C, Lombardi D, De Giorgi U, Andreetta C, Cinieri S, De Angelis C, Priolo D, Casanova C, Rosati M, Greco F, Zafarana E, Schiavetto I, Mammoliti S, Cecere SC, Salutari V, Scalone S, Farolfi A, Di Napoli M, Lorusso D, Gargiulo P, Califano D, Russo D, Spina A, De Cecio R, Chiodini P, Perrone F; MITO investigators. Pignata S, et al. Among authors: scalone s. Lancet Oncol. 2023 Mar;24(3):286-296. doi: 10.1016/S1470-2045(23)00016-5. Epub 2023 Feb 14. Lancet Oncol. 2023. PMID: 37052965 Clinical Trial.
Hormone therapy in elderly breast cancer patients with comorbidities.
Crivellari D, Spazzapan S, Puglisi F, Fratino L, Scalone S, Veronesi A. Crivellari D, et al. Among authors: scalone s. Crit Rev Oncol Hematol. 2010 Jan;73(1):92-8. doi: 10.1016/j.critrevonc.2009.02.003. Crit Rev Oncol Hematol. 2010. PMID: 19349190 Review.
Treatment of older breast cancer patients with high recurrence risk.
Crivellari D, Spazzapan S, Lombardi D, Berretta M, Magri MD, Sorio R, Scalone S, Veronesi A. Crivellari D, et al. Among authors: scalone s. Crit Rev Oncol Hematol. 2003 Jun;46(3):241-6. doi: 10.1016/s1040-8428(03)00023-4. Crit Rev Oncol Hematol. 2003. PMID: 12791423 Review.
Therapeutic management of breast cancer in the elderly.
Spazzapan S, Crivellari D, Bedard P, Lombardi D, Miolo G, Scalone S, Veronesi A. Spazzapan S, et al. Among authors: scalone s. Expert Opin Pharmacother. 2011 Apr;12(6):945-60. doi: 10.1517/14656566.2011.540570. Epub 2011 Feb 16. Expert Opin Pharmacother. 2011. PMID: 21323593 Review.
Prospective, Multicenter Phase II Trial of Non-Pegylated Liposomal Doxorubicin Combined with Ifosfamide in First-Line Treatment of Advanced/Metastatic Soft Tissue Sarcomas.
Buonadonna A, Scalone S, Lombardi D, Fumagalli A, Guglielmi A, Lestuzzi C, Polesel J, Canzonieri V, Lamon S, Giovanis P, Gagno S, Corona G, Mascarin M, Belluco C, De Paoli A, Fasola G, Puglisi F, Miolo G. Buonadonna A, et al. Among authors: scalone s. Cancers (Basel). 2023 Oct 18;15(20):5036. doi: 10.3390/cancers15205036. Cancers (Basel). 2023. PMID: 37894403 Free PMC article.
56 results